While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year. Research has found that cycling off these medications can bring potential rebound risks, ranging from rapid weight regain to the loss of cardiovascular protection. Dr. Frank Dumont, internal medicine … Read more
By the end of their first year on GLP-1s, more than half of patients stop taking the medication. There are a number of reasons for this, including high costs, unpleasant side effects and satisfaction with the weight they’ve already lost. The catch: stop taking GLP-1s, and the weight is likely to come back fast. And … Read more
You’re going to want to keep an eye on this. The Food and Drug Administration warned Monday that GLP-1 drugs may raise the risk of a rare but serious condition that can lead to permanent blindness. The agency is ordering drugmakers to update safety labels on their popular weight-loss and diabetes treatments, alerting patients and … Read more
Blame the beefcakes. America’s beef obsession is colliding with a cattle crisis. US cattle inventory fell to a 75-year low earlier this year, even as demand remains historically high. Add a war with Iran affecting diesel prices and supply chains disrupting fertilizer and feed costs — the result? Soaring beef prices and draining household budgets. … Read more
An unexpected shot of bad news. A popular weight-loss shot has been recalled across the country by the FDA due to potential contamination. The US-based compounding pharmacy that issued the initial recall back in September had already been on the agency’s radar and previously received a warning. Apothecary Pharma is recalling compounded versions of popular … Read more
Weight loss drugs may do more than melt away pounds — they could melt away years. Pharmaceutical companies and makers of GLP-1 medications, Eli Lilly and Novo Nordisk, say the blockbuster drugs can slow biological aging. The notable difference in reversed aging adds evidence that the jabs and pills might be a true longevity treatment. … Read more
This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11% — meaning more than one in 10 adults are on one form or another of the jab. This explosion in use of drugs like Ozempic, Wegovy and Mounjaro has happened over a very short time — about … Read more
Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The Massachusetts dad of four and beloved softball coach was just about the retire. Meanwhile, his sight was getting worse by the day. He desperately tried to nail down the cause quickly, but his vision loss deteriorated even … Read more
As GLP-1 medications continue reshaping the treatment of obesity and diabetes, researchers are also investigating whether the drugs could influence cancer risk and outcomes. The American Association for Cancer Research’s 2026 Cancer Progress Report, released earlier this month, noted that obesity is a major risk factor for many cancers. As glucagon-like peptide-1 medications – including … Read more
Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that the medications caused NAION (nonarteritic anterior ischemic optic neuropathy), according to The Wall Street Journal. NAION is a rare eye condition in which … Read more
It was the modern version of an indecent proposal. Shaylee Meurer, a 36-year-old plus-size influencer, once received a shocking offer from a major pharmacy brand: Take a popular GLP-1 drug for free, post about it on social media and reap a $7,000 reward. The big-time bid came at a vulnerable time for the content creator, … Read more
Two common GLP-1 weight loss drugs have been linked to a brain condition that can cause permanent brain damage and become deadly. More than one in 10 American adults are now on GLP-1s for weight loss. And while the jabs work to shed pounds and provide a host of other unexpected benefits, they can come … Read more
Stamie Giallourakis was on her deathbed in early 2021 when she made herself a promise. At the time, she was over 200 pounds and hospitalized with severe COVID-19. “I swore that if I survived — and I’m not being dramatic — I would try to once and for all be as healthy as I could … Read more
Talk about losing face. By now, people are well aware of “Ozempic face,” the phenomenon in which people on GLP-1 medications notice saggy skin, sunken eyes and gaunt cheeks. Now, “temporal wasting” is the latest side effect that prematurely ages weight loss drug users, and has doctors concerned. Along with “Ozempic face,” another side effect … Read more
July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37 percent higher than in … Read more
America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two years. Now, the shift is showing up on the scale, with national obesity rates edging lower after years … Read more
A woman went to the ER to deal with severe abdominal pain, nausea, and vomiting. She thought it might be due to stress. It turned out to be a goopy green mass that formed in her stomach — with a little help from her GLP-1. The 63-year-old was seen by doctors at Brigham and Women’s … Read more
There’s a nasty new job hazard to building employees in NYC’s most pampered zip codes — and it’s lurking in the trash. Residents at one luxe Upper East Side address received a sharp written warning after one staffer was shocked to discover they’d been jabbed by someone’s used needle while bagging building trash — and it wasn’t … Read more
The “fauxzempic” era is well underway. Many brands are marketing alternatives to GLP-1 weight-loss drugs, but certain foods may also boost the effects of the naturally occurring hormone responsible for reducing hunger and stabilizing blood sugar. A recent study found one diet that not only boosted GLP-1 but also increased longevity and reduced body fat. … Read more
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research. The study, set to be presented at ENDO 2026 (the Endocrine Society’s annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, “significantly reduced” their physical activity. In an Endocrine … Read more